for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Amicus Therapeutics announces approval for Galafold™ for treatment of Fabry disease in Canada

Sept 15 (Reuters) - Amicus Therapeutics Inc

* Amicus Therapeutics Inc announces approval for Galafold™ (Migalastat) for treatment of Fabry disease in Canada

* Amicus Therapeutics Inc - Amicus expects to make Galafold available to Canadian patients in coming weeks

* Amicus Therapeutics Inc says following Health Canada approval, Amicus expects to make Galafold available to Canadian patients in coming weeks Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up